We are live on ! Find out more
MYOV

Myovant Sciences Ltd.

Delisted

MYOV was delisted on the 9th of March, 2023.

104 hedge funds and large institutions have $624M invested in Myovant Sciences Ltd. in 2021 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 39 increasing their positions, 20 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

95% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 20

1% less funds holding

Funds holding: 105104 (-1)

3% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 29

18% less capital invested

Capital invested by funds: $765M → $624M (-$141M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

80% less call options, than puts

Call options by funds: $5.91M | Put options by funds: $29.9M

Holders
104
Holders Change
-1
Holders Change %
-0.95%
% of All Funds
1.83%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
28
Increased
39
Reduced
20
Closed
29
Calls
$5.91M
Puts
$29.9M
Net Calls
-$24M
Net Calls Change
-$21.1M
Name Holding Trade Value Shares
Change
Change in
Stake
Truist Financial
26
Truist Financial
North Carolina
$3.1M +$558K +24,500 +19%
BC
27
Blackcrane Capital
Washington
$2.92M +$1.65M +72,370 +104%
EWA
28
Evolution Wealth Advisors
Florida
$2.89M
UBS Group
29
UBS Group
Switzerland
$2.48M -$2.32M -101,953 -46%
Northern Trust
30
Northern Trust
Illinois
$1.84M +$1.81M +79,471 +782%
California Public Employees Retirement System
31
California Public Employees Retirement System
California
$1.81M -$187K -8,197 -9%
Swiss National Bank
32
Swiss National Bank
Switzerland
$1.7M +$29.6K +1,300 +2%
SF
33
Synovus Financial
Georgia
$1.59M +$308K +13,508 +21%
RJA
34
Raymond James & Associates
Florida
$1.55M -$278K -12,224 -14%
IHAM
35
Integral Health Asset Management
New York
$1.34M +$341K +15,000 +30%
Jane Street
36
Jane Street
New York
$1.31M +$1.09M +47,915 +304%
LBA
37
Letko, Brosseau & Associates
Quebec, Canada
$1.3M
TIP
38
Torray Investment Partners
Maryland
$1.3M +$30.9K +1,356 +2%
CAPTRUST Financial Advisors
39
CAPTRUST Financial Advisors
North Carolina
$906K +$27.5K +1,210 +3%
Bank of New York Mellon
40
Bank of New York Mellon
New York
$846K +$388K +17,031 +71%
Cambridge Investment Research Advisors
41
Cambridge Investment Research Advisors
Iowa
$796K +$94.8K +4,165 +12%
Point72 Asset Management
42
Point72 Asset Management
Connecticut
$790K +$874K +38,400 New
Two Sigma Investments
43
Two Sigma Investments
New York
$761K +$235K +10,329 +39%
Two Sigma Advisers
44
Two Sigma Advisers
New York
$714K +$790K +34,700 New
CS
45
Credit Suisse
Switzerland
$664K +$109K +4,777 +17%
Wells Fargo
46
Wells Fargo
California
$639K +$169K +7,440 +32%
UBS AM
47
UBS AM
Illinois
$610K -$231K -10,163 -26%
QI
48
QS Investors
New York
$576K +$637K +28,000 New
Group One Trading
49
Group One Trading
Illinois
$563K +$623K +27,376 New
Rockefeller Capital Management
50
Rockefeller Capital Management
New York
$512K +$567K +24,900 New

MYOV Hedge Fund Activity: Q1 2021 in Review

104 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Myovant Sciences Ltd. (MYOV) for Q1 2021, worth a combined $624M — down 18% from $765M a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of MYOV and 28 opened new positions — a net loss of 1 holder — while 20 trimmed existing stakes and 39 added.

The largest buyer was Wellington Management Group, adding an estimated $44.2M. The largest seller was Victory Capital Management, exiting entirely with an estimated $47.2M sold.

  • 104 institutional investors held Myovant Sciences Ltd. (MYOV) as of Q1 2021, down from 105 in Q4 2020.
  • Funds reported $624M of Myovant Sciences Ltd. stock for Q1 2021, down 18% quarter-over-quarter.
  • 28 funds opened new Myovant Sciences Ltd. positions in Q1 2021 and 29 closed out, a net change of -1 holder.
  • The largest Myovant Sciences Ltd. buyer in Q1 2021 was Wellington Management Group, an estimated $44.2M added.
  • The largest Myovant Sciences Ltd. seller in Q1 2021 was Victory Capital Management, an estimated $47.2M sold.

Based on aggregated 13F filings for Q1 2021.